… cells from progeny of pluripotent or multipotent cells. Both embryonic stem cells (derived
from the inner cell mass of a blastocyst) and adult stem cells (found in the postnatal organism) …

… Stem cell therapy is a promising therapeutic modality for advanced diabetes mellitus (DM). …
relevant clinical trials to determine the efficacy of stem cell therapy in DM. We aim to critically …

… beta-cells in patients with diabetes should continue to be explored. The role of adult stem
cells in the formation of new beta-cells is controversial, and the origin of such cells is unclear. …

… possible to obtain ªcustomisedº embryonic stem cells that could be induced to differentiate
into human tissues and cell lineages useful for cell therapy of diseases like diabetes mellitus. …

… To determine the impact of different stem cells on diabetes treatment, we conducted subgroup
meta-analyses according to cell type. Our analysis showed significant HbA1c reduction …

… Mesenchymal stem cells (MSCs) have emerged as a new cell therapeutic tool in regenerative
medicine. The ability of MSCs to differentiate into a variety of cell types from all three germ …

… Stem cell therapy is a promising alternative for islet transplantation in … stem cell therapies
in diabetes mellitus are multiple, including embryonic stem cells (ESCs), cord blood stem cells, …

… to be addressed before stem cell therapy will be clinically feasible for diabetic patients. In
this … cells (IPCs) from different precursor cells and in stem cell-based therapies for diabetes. …

… into the pathophysiology of diabetes. Also, we describe challenges for their clinical use …
diabetes cell therapy. Differentiation of Pluripotent Stem Cells into Insulin-Secreting β Cells: …

… Sustained insulin independence after autologous hematopoietic stem cell transplantation
in nine type 1 diabetic patients. No patient had diabetic ketoacidosis or used corticosteroids …